Hexagon Nutrition IPO: Complete Analysis, Dates, Price Band & In-Depth Review
The health and wellness sector has been experiencing exponential growth worldwide, driven by rising consumer awareness and preventive healthcare trends. Making its foray into the public markets to capitalize on this sentiment, Hexagon Nutrition Limited is set to launch its Initial Public Offering (IPO). This much-anticipated book-built issue is entirely an Offer for Sale (OFS), providing a significant opportunity for investors looking to gain exposure to the research-driven nutritional segment.
In this comprehensive guide, we dissect everything you need to know about the Hexagon Nutrition IPO, from its fundamental business model and financial health to its crucial timeline, valuation metrics, and overall market prospects.
Understanding Hexagon Nutrition: Business Model & Operations
Established in 1993, Hexagon Nutrition is a renowned research-driven nutrition company. The firm specializes in the formulation and manufacturing of high-quality health products, targeting both domestic and international markets. Operating across a PAN-India omnichannel distribution network, the company integrates retail pharmacies, hospital tie-ups, online platforms, and proprietary branded websites.
Core Business Segments
- Branded Wellness & Clinical Nutrition (B2C): Direct-to-consumer health supplements featuring well-known in-house brands like Pentasure, Obesigo, Pediagold, and Nutrone.
- Premix Formulations (B2B2C): Developing customized micronutrient premixes used by other fast-moving consumer goods (FMCG) and dietary supplement brands globally.
- Ready-to-Use Foods (RUFs) & Micronutrient Powders: Catering primarily to ESG (Environmental, Social, and Governance) initiatives fighting global malnutrition.
Manufacturing and Global Footprint
The company boasts a robust manufacturing infrastructure with three advanced facilities located in Nasik (Maharashtra), Chennai (Tamil Nadu), and Thoothukudi (Tamil Nadu). The units in Chennai and Thoothukudi are strategically positioned within Special Economic Zones (SEZ), granting the company lucrative duty-free import benefits and seamless port access. Moreover, it runs an international unit in Tashkent, Uzbekistan. With corporate offices spanning South Africa, Uzbekistan, and Hong Kong, Hexagon's products successfully reach over 75 countries across Asia, Africa, Europe, and South America.
Hexagon Nutrition IPO Details
The Hexagon Nutrition IPO is structured purely as an Offer for Sale (OFS) amounting to ₹138.87 Crores. Here are the core specifications of the issue:
| Key Attribute | Detail |
|---|---|
| Issue Type | Bookbuilding IPO (Mainboard) |
| Total Issue Size | ₹138.87 Crores (3,08,59,704 equity shares) |
| Offer for Sale (OFS) Size | ₹138.87 Crores (3,08,59,704 equity shares) |
| Price Band | ₹42 to ₹45 per equity share |
| Face Value | ₹1 per share |
| Lot Size (Minimum Bid) | 333 Shares |
| Listing Platforms | BSE & NSE |
| QIB Quota | Maximum 50.00% of the Net Offer |
| Retail Quota | Minimum 35.00% of the Net Offer |
| NII (HNI) Quota | Minimum 15.00% of the Net Offer |
Critical Dates: IPO Timeline
Mark your calendars. Below is the scheduled timeline spanning from the opening date of the IPO to its targeted stock market debut.
| Event | Tentative Date | Day |
|---|---|---|
| Bid Opening Date | June 5, 2026 | Friday |
| Bid Closing Date | June 9, 2026 | Tuesday |
| Finalization of Allotment | June 10, 2026 | Wednesday |
| Initiation of Refunds | June 11, 2026 | Thursday |
| Credit of Shares to Demat | June 11, 2026 | Thursday |
| Stock Exchange Listing | June 12, 2026 | Friday |
Investment Quotas & Lot Sizes
Retail investors and High Net-worth Individuals (HNIs) must apply for shares in specific lot multipliers. For the Hexagon Nutrition IPO, one lot consists of 333 shares.
| Investor Category | Minimum / Maximum | Lots | Total Shares | Total Amount (at Upper Band ₹45) |
|---|---|---|---|---|
| Retail Individual Investor | Minimum | 1 Lot | 333 | ₹14,985 |
| Retail Individual Investor | Maximum | 13 Lots | 4,329 | ₹1,94,805 |
| Small HNI (sNII) | Minimum | 14 Lots | 4,662 | ₹2,09,790 |
| Small HNI (sNII) | Maximum | 66 Lots | 21,978 | ₹9,89,010 |
| Big HNI (bNII) | Minimum | 67 Lots | 22,311 | ₹10,03,995 |
Financial Health & Performance
A steady evaluation of the balance sheet defines the fundamental strength of the business. Hexagon Nutrition showcases an upward trajectory in its net worth over the documented fiscal periods. Let us analyze the core financial metrics:
| Financial Parameter (in ₹ Crore) | As of Dec 31, 2025 | FY Ended Mar 31, 2025 | FY Ended Mar 31, 2024 |
|---|---|---|---|
| Total Assets | 327.60 | 261.36 | 250.54 |
| Total Income (Revenue) | 275.57 | 331.29 | 304.62 |
| Profit After Tax (PAT) | 27.03 | 24.38 | 12.21 |
| EBITDA | 37.55 | 40.07 | 24.88 |
| Net Worth | 223.05 | 195.60 | 176.29 |
| Total Borrowing | 39.79 | 26.60 | 36.89 |
Insight: The firm’s profitability has shown a remarkable leap. The PAT doubled from ₹12.21 Cr in FY 2024 to ₹24.38 Cr in FY 2025, and continues strongly into the December 2025 period at ₹27.03 Cr. Meanwhile, debt-to-equity remains highly manageable.
Key Performance Indicators (Valuation)
| Metric | Value (As of Dec 2025 / FY25) |
|---|---|
| Return on Equity (ROE) | 13.02% |
| Return on Capital Employed (ROCE) | 14.82% |
| Debt to Equity Ratio | 0.18 |
| Pre-IPO EPS (Earnings Per Share) | ₹1.98 |
| Price to Earnings (P/E) Ratio | 15.35 to 22.69 (Approximate range) |
| Pre-IPO Market Capitalization | ₹553.13 Crores |
Objectives of the Issue
Since the Hexagon Nutrition IPO is entirely an Offer for Sale (OFS) of 3,08,59,704 shares, the proceeds of this issue will go directly to the selling shareholders and promoters. The company itself will not receive any funds from this public offering. However, listing on the mainboard exchanges (BSE & NSE) will naturally enhance the company’s corporate brand image and provide liquidity to existing shareholders.
Promoter Holding & Management
The corporate leadership driving Hexagon Nutrition comprises experienced promoters: Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Vikram Arun Kelkar, and Nikhil Arun Kelkar.
- Pre-Issue Promoter Shareholding: 89.41%
- Post-Issue Promoter Shareholding: 64.29%
Even after the OFS dilution, the promoters will retain a solid majority stake of 64.29%, signaling continued confidence and a vested interest in the long-term governance of the business.
Strategic Evaluation: SWOT Analysis
To assist in maintaining an objective perspective, we have mapped out a comprehensive SWOT (Strengths, Weaknesses, Opportunities, Threats) profile for Hexagon Nutrition.
Strengths
- Proprietary in-house R&D centers (Nasik & Chennai) ensuring product innovation.
- Diversified portfolio blending B2C wellness brands and B2B premix formulations.
- Robust export channels across 75+ global markets.
- Strategic SEZ-based manufacturing yielding tax and logistics advantages.
Weaknesses
- Total reliance on Offer for Sale (OFS) structure meaning zero fresh capital infusion for business expansion.
- High dependence on a network of 358+ third-party distributors for domestic sales.
Opportunities
- Surging global demand for preventive healthcare and clinical nutritional supplements.
- Potential to penetrate deeper into untapped rural demographics and emerging international markets.
- Expansion of e-commerce and direct-to-consumer digital channels.
Threats
- Aggressive competition from global pharmaceutical MNCs and established domestic FMCG giants.
- Stringent regulatory shifts by food and drug authorities across different countries.
- Volatility in the prices of raw materials impacting EBITDA margins.
IPO Intermediaries & Corporate Contacts
For application status, allotment queries, and corporate communications, investors should refer to the officially appointed intermediaries.
| Entity Type | Details |
|---|---|
| Registrar to the Issue | Kfin Technologies Ltd. Email: hexagon.ipo@kfintech.com Phone: 040-67162222 / 040-79611000 |
| Book Running Lead Managers | Cumulative Capital Pvt. Ltd. Catalyst Capital Partners Pvt. Ltd. |
| Company Registered Office | Hexagon Nutrition Ltd. 404 Global Chamber, Adarsh Nagar Link Road, Andheri (W), Mumbai, Maharashtra, 400053 Email: cs.hnpl@hexagonnutrition.com |
Final Thoughts
The Hexagon Nutrition IPO presents a highly structured entry into the burgeoning nutraceutical space. Backed by solid revenue growth, a doubling of profits over the last few fiscal cycles, and a diverse global footprint spanning over 75 countries, the underlying business fundamentals look resilient. The pricing band of ₹42 to ₹45 leaves a reasonable valuation on the table, yielding a pre-IPO market cap of roughly ₹553.13 Crores.
While the 100% OFS structure dictates that the company won't receive immediate growth capital from the public issue, the robust existing balance sheet and low debt-to-equity ratio provide a reliable cushion. Before applying, potential investors should weigh the competitive threats in the FMCG sector against the long-term global shift toward clinical and branded wellness nutrition.